May 15, 2019 / 06:20PM GMT
Jason Matthew Gerberry - BofA Merrill Lynch, Research Division - MD in US Equity Research
Here with our next company presenter. My name is Jason Gerberry. I'm the U.S. pharma analyst at Bank of America. I'm pleased to be presenting -- or introducing, I should say, Bausch Health Companies' CEO, Joe Papa. Bausch is a diversified spec pharma company with eye care, dermatology and GI. So Joe, I don't know if you wanted to make any brief introductory remarks or you want to just jump right into Q&A.
Joseph C. Papa - Bausch Health Companies Inc. - CEO & Chairman of the Board
Yes. I'd be delighted, first of all, to thank you for the opportunity to be here. I'm delighted to have a chance to talk about Bausch Health. We've started a process of a transition where we are transformationing Bausch Health, and we're really excited about the latest quarterly results. In the latest quarterly results, we had the chance to talk about 5% organic growth, which fit with our theme for 2019 about pivoting to offense. So clearly, we're able to show that.
If you then
Bausch Health Companies Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers